shorts that piled in after the Merck agreement have made a big, big mistake - this could easily double

31% YOY REV GROWTH, 10.7 TTM PE, MODEST DEBT, PRICED AT JUST PENNIES OVER BOOK VALUE, JUST FINISHED EXTENSIVE CAPITAL EQUIPMENT MODERNIZATION PROGRAM, LONG TERM AGREEMENTS WITH GOOD CUSTOMERS, LIMITED ANALYST COVERAGE SO FAR, RELATIONSHIP WITH SPIL NOT APPRECIATED YET BY ANALYSTS - CHRONIC WEAK SISTER SHAREHOLDERS MAY FINALLY HAVE BEEN SHAKEN OUT IN RECENT RUN-UP TO $7.50 THIS STOCK SHOULD BE TRADING IN THE TWENTIES - WAY, WAY UNDERVALUED

LONG OVERDUE FOR A RUN-UP, REV GROWTH WILL ACCELERATE IN 3RD & 4TH QUATERS

REV GROWTH WILL ACCELERATE IN 3RD & 4TH QUARTERS

THE SLIGHTED BIT OF GOOD NEWS SHOULD SEND THIS STOCK STRAIGHT UP. THEY HAVEN'T HAD ANY FOR AGES.

the frauds at citron research should be thrown in jail and their followers castrated then force-fed the results. HSOA will report surprisingly good rev/eps in coming quarters. Construction is a messy business - it's easy to criticize what permits get filed when - doesn't mean the projects won't go forward - try getting an addition to your house built and you'll see what I mean.

Drilling started on first of three initial wells in three large separate claims off Trinidad and Tobago - will hit a monster sized reservoir of nat gas within two months with first well and stock will skyrocket. Co. also holds title to huge tracts of oil & gas rich lands in Canada and offshore Nova Scotia - soon to start development of.